Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| Frankfurt | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| Moscow | RUB | Real-time | ||
| KASE | KZT | Delayed | ||
| Lima | USD | Delayed |
Pfizer Inc. (NYSE: PFE) shares have lagged the S&P 500 in 2021, generating a year-to-date total return of 16.6%.Pfizer has gotten plenty of headlines for its COVID-19 vaccine, but...
Pfizer and BioNTech have submitted data to the European Medicines Agency to support their COVID-19 vaccine for use in children between the ages of 5 and 11 years old.
Pfizer (PFE) announces that the EMA's CHMP has adopted positive recommendations on the company's abrocitinib and XELJANZ (tofacitinib) treatments.Abrocitinib 100 mg and 200 mg...
NIH-Backed Study Finds Moderna, Pfizer Boosters Work BestAfter months of dithering about the potential safety risks of mixing and matching various approved COVID vaccines, a...
Approved Version Of Pfizer's COVID-19 Vaccine Still Not Available In USAuthored by Zachary Stieber and Meiling Lee via The Epoch Times,The approved version of...
Pfizer Asks FDA To Approve COVID Jab For Children As Young As 5Nearly three weeks after Pfizer and BioNTech released data purporting to show that their COVID jab is safe and...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Strong Buy | Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Buy | Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 515.74 | 521.34 | 512.50 | -2.31 | -0.45% | 32.35K | Toronto | |||
| 0.59 | 0.00 | 0.00 | -0.05 | -7.81% | 804.22K | TSXV | |||
| 5.60 | 5.63 | 5.60 | -0.02 | -0.36% | 490.00 | TSXV | |||
| 18.61 | 18.80 | 18.61 | -0.11 | -0.59% | 3.50M | Toronto | |||
| 0.26 | 0.00 | 0.00 | -0.01 | -5.56% | 38.63K | Toronto | |||
| 10.17 | 10.52 | 10.16 | -0.16 | -1.55% | 335.11K | Toronto | |||
| 1.55 | 1.60 | 1.55 | 0.00 | 0.00% | 0.00 | NEO | |||
| 66.39 | 66.46 | 65.26 | +1.39 | +2.14% | 6.71M | Toronto | |||
| 30.99 | 31.29 | 30.73 | -0.19 | -0.61% | 737.80K | Toronto | |||
| 87.01 | 87.08 | 86.00 | +1.50 | +1.75% | 6.62M | Toronto | |||
| 0.28 | 0.00 | 0.00 | -0.0050 | -1.75% | 486.79K | Toronto | |||
| 47.17 | 47.79 | 46.78 | +0.13 | +0.28% | 70.25K | Toronto | |||
| 2.67 | 2.74 | 2.48 | 0.000 | 0.00% | 109.70K | Toronto | |||
| 9.81 | 9.85 | 9.73 | +0.08 | +0.82% | 94.03K | Toronto | |||
| 6.84 | 6.89 | 6.70 | +0.10 | +1.48% | 261.74K | Toronto |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.